Vijay Yeldandia was an energetic and rambunctious toddler when he was growing up in India. But at the age of two, he came ...

When it comes to what’s happening in the life sciences, STAT readers are the experts. So earlier this month, I asked readers ...

The CDC said Thursday that the mutations, detected in a sample taken from a Louisiana patient, may help bind the virus to the ...

In STAT's "jealousy list" for 2024, STAT staffers explain what makes a selection of stories they read in other publications ...

Here we are, on the cusp of the midway point in a decade that has been, in global health and infectious diseases terms, a lot ...

Whether the next pandemic is caused by H5N1 bird flu or something else, we must prepare now to use convalescent plasma to ...

STAT '3 to Watch' series looks at biotech industry issues in 2025: Trump administration uncertainties, pharma deals in China, ...

The killing of UnitedHealthcare CEO Brian Thompson has sparked extraordinary public interest in the nation’s health insurance industry. Much of the outcry has centered not on the killing itself ...

The “skin in the game” experiment has failed to achieve its primary raison d’être. Over the past two decades, it has not ...

One of those experts was Stanley Biber, a pioneer of vaginoplasties in the U.S. and perhaps the country’s busiest ...

Retractions are meant to maintain trust in science — but on social media, they're often used to reinforce anti-science bias ...

Bone marrow transplants, long a mainstay of blood cancer treatments, are becoming less common in favor of options like CAR-T ...